Products
Online Inquiry
IWP-2
Cat. No.:
OB0225WX-1621
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
IWP-2 is an inhibitor of the Wnt signaling pathway with an IC50 of 27 nM, while also functioning as an ATP-competitive inhibitor of CK1δ with an IC50 of 40 nM against M82FCK1δ.
Synonym:
IWP2; 686770-61-6; IWP-2; IWP 2; N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide; N-(6-methylbenzo[d]thiazol-2-yl)-2-((4-oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide; N-(6-Methylbenzo[d]thiazol-2-yl)-2-(4-oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-ylthio)acetamide; Wnt Inhibitor IWP-2; MFCD04457599; N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamide; Inhibitor of Wnt Production-2; N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]; N -(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrimidin-2-yl)thio]-acetamide; N -(6-Methyl-2-benzothiazolyl)-2-[(3a?4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrimaidin-2-yl)thio]-acetamide; N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide; N-(6-Methyl-2-benzothiazolyl)-2-[(3 ,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide
CAS No.:
686770-61-6
Compound CID:
2155128
Formula:
C22H18N4O2S3
Formula Weight:
466.6
Specification
Targets&IC50:
Wnt: 27 nM
Relative Density:
1.52 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
IWP-2 is utilized in regenerative medicine and cell signaling research to investigate the mechanisms of cardiomyocyte differentiation and the disruption of Wnt-mediated signaling pathways.
Library Information
Target:
Wnt/β-Catenin; Casein kinase; Porcn
Receptor:
Casein kinase; Porcn; Wnt
Pathways:
Stem cells; Metabolism; Cytoskeletal signaling
Plate Number:
AOCL-21
Plate Location:
g6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM Water
DMSO Max Solubility:
<1 mg/mL
ALogP:
4.277
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
5





